Glad to set the CYDY record straight. “Nader has made some mistakes” is quite the under statement. If this company was on NASDAQ, or had some institutional investors, Nader would have been gone long ago. There is zero board oversight. I will only go with :
Nader Purposely submitted a deficient HIV BLA to the FDA ( for the sake of brevity.) That is fact based on emails to Amarex from Nader, released in the current litigation.
That concept should be dwelt upon and scare the absolute hell out of every investor.
There are many more fireable offenses.
The RTF cost CYDY $100s of millions and much credibility with the FDA. It is easy to research the impact of RTF on a drug and company. And it was submitted, not only with full knowledge of the CEO, but he demanded it be submitted. Then lies were told regarding the reasons for the RTF while Nader sold over 4 million shares, (immediately after the submission) the vast majority of his stake.
I invested based on LL. Nader has succeeded in making Cydy and LL about him. IT IS NOT.
The knock on Nader is Not a knock on cydy or LL, it is a knock on Nader…period.
I have yet to see my question answered regarding incompetent management allowing a company to succeed.
It doesn’t work that way. A mediocre product can succeed with great management, but a great product will fail with poor management.
What is the evidence this team can commercialize LL?
News 
Market Data 
Discover 
AI
